Segment & Geographic Data
Quant-Grade Normalized Data
API & CSV Delivery
Vyant Bio Inc's Business Segments
Vyant Bio Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
-
Regions Reported
-
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/VYNT/segments
https://api.csimarket.com/api/v1/companies/VYNT/geographic
https://api.csimarket.com/api/v1/companies/VYNT/exposure
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Connect Your AI Assistant
Annual Results
Revenue by Product & Service Category -
- Product85.1%
- Service14.9%
Revenue by Product & Service Category -
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 1 | 85.1% |
| Service | $ 0 | 14.9% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Vyant Bio Inc
Vyant Bio Inc is a leading biotechnology company focused on revolutionizing healthcare and diagnostics through the integration of advanced analytics and machine learning techniques. The company is headquartered in West Henrietta, New York, and has operations globally.
Vyant Bio is known for its expertise in developing and commercializing cutting-edge technologies for the life sciences industry. Their primary focus is on leveraging the power of artificial intelligence (AI) and data analytics to accelerate drug discovery and development, biomarker identification, and personalized medicine.
The company's flagship platform, VyantIQ, is a cloud-based data analytics platform that combines proprietary algorithms and machine learning models with vast amounts of biological and clinical data. This platform enables researchers and healthcare professionals to rapidly analyze complex datasets, identify patterns, and generate critical insights to inform decision-making processes.
Vyant Bio has a diverse portfolio of products and services that cater to a wide range of applications in the life sciences field. One of their key offerings is precision medicine solutions, which involve the identification of genomic, proteomic, and metabolomic markers and the development of personalized treatment plans based on an individual's unique genetic makeup.
The company also specializes in developing advanced diagnostic tests for a variety of diseases and conditions. Their diagnostic solutions leverage state-of-the-art technologies, such as next-generation sequencing and high-throughput screening, to provide accurate and reliable results in a timely manner.
In addition to their technological innovations, Vyant Bio has built strong collaborations with leading academic institutions, pharmaceutical companies, and healthcare organizations. These strategic partnerships allow them to access a vast network of expertise, resources, and data, further enhancing the value they bring to their customers.
Vyant Bio is committed to driving positive change in the healthcare industry by addressing challenges such as drug resistance, treatment variability, and high drug development costs. They aim to improve patient outcomes and increase the efficiency and effectiveness of healthcare systems worldwide.
Overall, Vyant Bio Inc is a pioneering biotechnology company that is at the forefront of leveraging advanced analytics and machine learning to transform healthcare and diagnostics. Through their innovative solutions, they are revolutionizing the way diseases are diagnosed, treated, and managed, ultimately shaping the future of personalized medicine.
Vyant Bio is known for its expertise in developing and commercializing cutting-edge technologies for the life sciences industry. Their primary focus is on leveraging the power of artificial intelligence (AI) and data analytics to accelerate drug discovery and development, biomarker identification, and personalized medicine.
The company's flagship platform, VyantIQ, is a cloud-based data analytics platform that combines proprietary algorithms and machine learning models with vast amounts of biological and clinical data. This platform enables researchers and healthcare professionals to rapidly analyze complex datasets, identify patterns, and generate critical insights to inform decision-making processes.
Vyant Bio has a diverse portfolio of products and services that cater to a wide range of applications in the life sciences field. One of their key offerings is precision medicine solutions, which involve the identification of genomic, proteomic, and metabolomic markers and the development of personalized treatment plans based on an individual's unique genetic makeup.
The company also specializes in developing advanced diagnostic tests for a variety of diseases and conditions. Their diagnostic solutions leverage state-of-the-art technologies, such as next-generation sequencing and high-throughput screening, to provide accurate and reliable results in a timely manner.
In addition to their technological innovations, Vyant Bio has built strong collaborations with leading academic institutions, pharmaceutical companies, and healthcare organizations. These strategic partnerships allow them to access a vast network of expertise, resources, and data, further enhancing the value they bring to their customers.
Vyant Bio is committed to driving positive change in the healthcare industry by addressing challenges such as drug resistance, treatment variability, and high drug development costs. They aim to improve patient outcomes and increase the efficiency and effectiveness of healthcare systems worldwide.
Overall, Vyant Bio Inc is a pioneering biotechnology company that is at the forefront of leveraging advanced analytics and machine learning to transform healthcare and diagnostics. Through their innovative solutions, they are revolutionizing the way diseases are diagnosed, treated, and managed, ultimately shaping the future of personalized medicine.
As of the last available information, Vyant Bio Inc. is a biotechnology company that focuses on developing innovative solutions and therapies primarily for neurodevelopmental disorders and related conditions. The company leverages its proprietary technology platforms to create human neuroscience models and drug discovery processes. Below is an extensive overview of the segments, products, and services offered by Vyant Bio Inc.
Segments
1. Drug Discovery:
Vyant Bio operates in the drug discovery segment, focusing on identifying and developing treatments for various central nervous system (CNS) disorders. The drug discovery efforts typically concentrate on neurodevelopmental diseases, leveraging the companys advanced platforms to find new targets and compounds.
2. Modeling and Screening Platforms:
The company provides advanced modeling and screening platforms, which are utilized for preclinical testing of compounds. These platforms are designed to replicate human neural conditions, facilitating more accurate predictions of drug efficacy and safety in human subjects.
3. Therapeutic Development:
Vyant Bio is also involved in therapeutic development, working towards bringing new drug candidates through various stages of preclinical and clinical development, with the aim of addressing unmet medical needs in neurological conditions.
Products and Services
1. Human Neuronal Platforms:
- Vyant Bio has developed state-of-the-art human neuronal platforms that allow researchers to create neuron-like cells from induced pluripotent stem cells (iPSCs). These platforms enable the study of neurodevelopmental processes and disease mechanisms.
- The platforms can be used to model various CNS diseases, providing insights into drug responses and potential therapeutic strategies.
2. Assay Development Services:
- The company offers customizable assay development services that allow clients to optimize and validate assays for drug screening purposes. This results in more effective drug discovery processes by using physiologically relevant models.
- These services may include high-throughput screening capabilities, which can assist in identifying lead compounds.
3. Consulting Services:
- Vyant Bio may provide consulting services to pharmaceutical and biotechnology companies, utilizing their expertise in CNS drug development to assist clients in navigating complex drug development challenges.
- This could involve strategic planning for preclinical studies or guidance on clinical trial designs.
4. Partnerships and Collaborations:
- The company actively seeks partnerships with other biopharmaceutical entities, academic institutions, and research organizations to expand the reach of its technologies and accelerate drug discovery efforts.
- Such collaborations may result in joint development agreements, sharing of proprietary technologies, or co-investment in specific research projects.
5. Licensing of Technologies:
- Vyant Bio may offer licensing opportunities for its proprietary technologies, allowing other companies to utilize their innovative methodologies in their own drug discovery processes.
- This not only provides a revenue stream for Vyant Bio but also expands the accessibility of their platforms.
6. Therapeutic Pipeline:
- Vyant Bio has a pipeline of therapeutic candidates targeting diseases such as Autism Spectrum Disorder (ASD) and other neurodevelopmental disorders. The specifics of the pipeline often include various preclinical and clinical-stage compounds that are being evaluated for safety and efficacy.
Publications and Scientific Contributions:
- The company is involved in scientific research and contributes to the broader scientific community through publications, presenting their findings at conferences, and collaborating on research projects. This helps to validate their scientific methodologies and attract attention from potential partners.
Through these segments, products, and services, Vyant Bio Inc. positions itself as a key player in the biotechnology field, especially concerning neurodevelopmental disorders, leveraging state-of-the-art human neuroscience models to expedite the drug discovery process.
Segments
1. Drug Discovery:
Vyant Bio operates in the drug discovery segment, focusing on identifying and developing treatments for various central nervous system (CNS) disorders. The drug discovery efforts typically concentrate on neurodevelopmental diseases, leveraging the companys advanced platforms to find new targets and compounds.
2. Modeling and Screening Platforms:
The company provides advanced modeling and screening platforms, which are utilized for preclinical testing of compounds. These platforms are designed to replicate human neural conditions, facilitating more accurate predictions of drug efficacy and safety in human subjects.
3. Therapeutic Development:
Vyant Bio is also involved in therapeutic development, working towards bringing new drug candidates through various stages of preclinical and clinical development, with the aim of addressing unmet medical needs in neurological conditions.
Products and Services
1. Human Neuronal Platforms:
- Vyant Bio has developed state-of-the-art human neuronal platforms that allow researchers to create neuron-like cells from induced pluripotent stem cells (iPSCs). These platforms enable the study of neurodevelopmental processes and disease mechanisms.
- The platforms can be used to model various CNS diseases, providing insights into drug responses and potential therapeutic strategies.
2. Assay Development Services:
- The company offers customizable assay development services that allow clients to optimize and validate assays for drug screening purposes. This results in more effective drug discovery processes by using physiologically relevant models.
- These services may include high-throughput screening capabilities, which can assist in identifying lead compounds.
3. Consulting Services:
- Vyant Bio may provide consulting services to pharmaceutical and biotechnology companies, utilizing their expertise in CNS drug development to assist clients in navigating complex drug development challenges.
- This could involve strategic planning for preclinical studies or guidance on clinical trial designs.
4. Partnerships and Collaborations:
- The company actively seeks partnerships with other biopharmaceutical entities, academic institutions, and research organizations to expand the reach of its technologies and accelerate drug discovery efforts.
- Such collaborations may result in joint development agreements, sharing of proprietary technologies, or co-investment in specific research projects.
5. Licensing of Technologies:
- Vyant Bio may offer licensing opportunities for its proprietary technologies, allowing other companies to utilize their innovative methodologies in their own drug discovery processes.
- This not only provides a revenue stream for Vyant Bio but also expands the accessibility of their platforms.
6. Therapeutic Pipeline:
- Vyant Bio has a pipeline of therapeutic candidates targeting diseases such as Autism Spectrum Disorder (ASD) and other neurodevelopmental disorders. The specifics of the pipeline often include various preclinical and clinical-stage compounds that are being evaluated for safety and efficacy.
Publications and Scientific Contributions:
- The company is involved in scientific research and contributes to the broader scientific community through publications, presenting their findings at conferences, and collaborating on research projects. This helps to validate their scientific methodologies and attract attention from potential partners.
Through these segments, products, and services, Vyant Bio Inc. positions itself as a key player in the biotechnology field, especially concerning neurodevelopmental disorders, leveraging state-of-the-art human neuroscience models to expedite the drug discovery process.